Repository logo
 
Publication

Effects of Local Anesthetic on the Time Between Analgesic Boluses and the Duration of Labor in Patient-Controlled Epidural Analgesia: Prospective Study of Two Ultra-Low Dose Regimens of Ropivacaine and Sufentanil

dc.contributor.authorCosta Martins, JM
dc.contributor.authorDias, CC
dc.contributor.authorPereira, M
dc.contributor.authorTavares, J
dc.date.accessioned2015-05-29T12:24:14Z
dc.date.available2015-05-29T12:24:14Z
dc.date.issued2015
dc.description.abstractBACKGROUND: Patient-controlled epidural analgesia with low concentrations of anesthetics is effective in reducing labor pain. The aim of this study was to assess and compare two ultra-low dose regimens of ropivacaine and sufentanil (0.1% ropivacaine plus 0.5 μg.ml-1 sufentanil vs. 0.06% ropivacaine plus 0.5 μg.ml-1 sufentanil) on the intervals between boluses and the duration of labor. MATERIAL AND METHODS: In this non-randomized prospective study, conducted between January and July 2010, two groups of parturients received patient-controlled epidural analgesia: Group I (n = 58; 1 mg.ml-1 ropivacaine + 0.5 μg.ml-1 sufentanil) and Group II (n = 57; 0.6 mg.ml-1 ropivacaine + 0.5 μg.ml-1 sufentanil). Rescue doses of ropivacaine at the concentration of the assigned group without sufentanil were administered as necessary. Pain, local anesthetic requirements, neuraxial blockade characteristics, labor and neonatal outcomes, and maternal satisfaction were recorded. RESULTS: The ropivacaine dose was greater in Group I (9.5 [7.7-12.7] mg.h-1 vs. 6.1 [5.1-9.8 mg.h-1], p < 0.001). A time increase between each bolus was observed in Group I (beta = 32.61 min, 95% CI [25.39; 39.82], p < 0.001), whereas a time decrease was observed in Group II (beta = -1.40 min, 95% CI [-2.44; -0.36], p = 0.009). The duration of the second stage of labor in Group I was significantly longer than that in Group II (78 min vs. 65 min, p < 0.001). CONCLUSIONS: Parturients receiving 0.06% ropivacaine exhibited less evidence of cumulative effects and exhibited faster second stage progression than those who received 0.1% ropivacaine.por
dc.identifier.citationActa Med Port. 2015 Jan-Feb;28(1):70-6por
dc.identifier.urihttp://hdl.handle.net/10400.17/2218
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherCentro Editor e Livreiro da Ordem dos Médicospor
dc.subjectMAC ANSpor
dc.subjectAmides/administration & dosagepor
dc.subjectAnalgesia, Patient-Controlledpor
dc.subjectAnalgesics/administration & dosagepor
dc.subjectAnalgesics, Opioid/administration & dosagepor
dc.subjectAnesthesia, Localpor
dc.subjectAnesthesia, Obstetrical
dc.subjectAnesthetics, Local/administration & dosage
dc.subjectLabor, Obstetric
dc.subjectPregnancy
dc.subjectProspective Studies
dc.subjectSufentanil/administration & dosage
dc.subjectTime Factors
dc.titleEffects of Local Anesthetic on the Time Between Analgesic Boluses and the Duration of Labor in Patient-Controlled Epidural Analgesia: Prospective Study of Two Ultra-Low Dose Regimens of Ropivacaine and Sufentanilpor
dc.title.alternativeEfeitos de Anestésico Local no Tempo Entre Bólus e na Duração do Trabalho de Parto em Patient-Controlled Epidural Analgesia: Estudo Prospectivo de Dois Regimes de Doses Ultra-Baixas com Ropivacaina e Sufentanilpor
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage76por
oaire.citation.startPage70por
oaire.citation.titleActa Médica Portuguesapor
rcaap.rightsopenAccesspor
rcaap.typearticlepor

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
AMP 2015.pdf
Size:
472.28 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections